Position in CABA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,533,497
+$4,781,448 QoQ
Shares Held
9,174,758
+3.9% QoQ
Ownership
5.41%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#5
of 139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. CABA ranks #41 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in CABA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,533,497 | 9,174,758 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,752,049 | 8,829,758 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,337,170 | 8,829,758 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,661,633 | 8,829,758 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,421,232 | 8,829,758 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,033,745 | 3,634,473 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,250,253 | 3,634,473 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,332,964 | 3,036,645 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,714,104 | 3,036,645 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $51,805,163 | 3,036,645 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $74,152,841 | 3,266,645 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $49,718,336 | 3,266,645 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,172,386 | 3,266,645 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $21,019,404 | 2,541,645 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,510,216 | 2,541,645 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,652,069 | 2,541,645 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,694,143 | 2,541,645 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,159,539 | 2,541,645 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,632,834 | 2,541,645 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $36,986,403 | 3,041,645 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $26,158,147 | 3,041,645 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $33,762,259 | 3,041,645 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $39,696,446 | 3,180,805 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $36,907,598 | 3,404,760 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $39,714,200 | 3,565,009 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $26,314,748 | 3,604,760 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||